On Monday, Pacific Biosciences of California Inc (NASDAQ: PACB) opened higher 3.95% from the last session, before settling in for the closing price of $1.77. Price fluctuations for PACB have ranged from $1.16 to $10.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 24.48% annually for the last half of the decade. Company’s average yearly earnings per share was noted 4.74% at the time writing. With a float of $259.36 million, this company’s outstanding shares have now reached $267.74 million.
In an organization with 796 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 19.6%, operating margin of -166.74%, and the pretax margin is -218.04%.
Pacific Biosciences of California Inc (PACB) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Pacific Biosciences of California Inc is 4.83%, while institutional ownership is 83.74%. The most recent insider transaction that took place on Sep 30 ’24, was worth 34,065. In this transaction an insider of this company sold 19,782 shares at a rate of $1.72, taking the stock ownership to the 695,654 shares. Before that another transaction happened on Sep 30 ’24, when Company’s Officer proposed sale 19,782 for $1.72, making the entire transaction worth $34,061.
Pacific Biosciences of California Inc (PACB) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.26 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.33) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.00% during the next five years compared to -9.76% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Check out the current performance indicators for Pacific Biosciences of California Inc (PACB). In the past quarter, the stock posted a quick ratio of 7.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Let’s dig in a bit further. During the last 5-days, its volume was 4.62 million. That was inferior than the volume of 9.34 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 18.67%. Additionally, its Average True Range was 0.15.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 61.82%, which indicates a significant increase from 57.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 122.09% in the past 14 days, which was higher than the 116.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6966, while its 200-day Moving Average is $2.7894. However, in the short run, Pacific Biosciences of California Inc’s stock first resistance to watch stands at $1.8700. Second resistance stands at $1.9000. The third major resistance level sits at $1.9450. If the price goes on to break the first support level at $1.7950, it is likely to go to the next support level at $1.7500. The third support level lies at $1.7200 if the price breaches the second support level.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
There are currently 272,356K shares outstanding in the company with a market cap of 501.46 million. Presently, the company’s annual sales total 200,520 K according to its annual income of -306,740 K. Last quarter, the company’s sales amounted to 36,010 K and its income totaled -173,320 K.
